The Levo System utilizes neuroscience-based therapy to reduce a patient’s tinnitus over time gradually. Its FDA-cleared, patented and proprietary software solution generates a customized sound match that precisely replicates the sound the patient is hearing. The patient will listen to their sound match at night for up to 8 hours for nine months to create neuroplastic changes in the brain, which will lead to a consistent and lasting reduction in tinnitus intensity over time.
Understanding Neuroplasticity
Neuroplasticity refers to the brain’s ability to adapt and change its structure and function in response to environmental influences. It involves the formation of new neural connections, the modification of existing connections and the reorganization of neural networks, enabling the brain to adapt, learn and recover from injuries or changes in its environment.
How Levo Works
Levo’s high-quality sound is generated by Apple hardware and premium earbuds, ensuring safe and precise administration of the therapy each night.
The Levo system administers therapy at night because sleep can be one of the most challenging times for tinnitus patients, and Levo has been proven to improve the quality of patients’ sleep significantly. In addition, there are many additional benefits to administering therapy during sleep:
- Auditory pathways remain active while sleeping. With fewer competing sensor inputs and cognitive demands, the neuroplastic response may be enhanced when acoustic stimulation occurs during sleep, thereby increasing the effectiveness of the therapy.
- Therapy at night does not interfere with daily activities, and because patients are not aware of the stimulation, it reduces treatment-related anxiety.
The Levo therapeutic protocol consists of three phases:
- Adaptation
- Continuous Stimulation
- Detachment/Maintenance
It is recommended that the Levo systems be used for up to nine months to maximize the potential for long-term benefits. However, an independent study published featuring the Levo System found that most patients saw improvements after three months of therapy.
After three months of therapy, another study found that patients experienced an average reduction of tinnitus intensity of 80%. This was accompanied by a 77% decrease in the average Tinnitus Functional Index (TFI).